Literature DB >> 7529916

Evidence for a second cell cycle block at G2/M by p53.

N Stewart1, G G Hicks, F Paraskevas, M Mowat.   

Abstract

Wild type p53 can induce cell cycle arrest at specific points in the cell cycle, in particular G1/S, an ability lost by most p53 mutants. We have previously reported that p53 mutant genes can rescue REF52 cells from ras-induced growth arrest and that over expression of wild type p53 inhibits cell growth in these cells. In this paper we examined whether p53 can also induce cell cycle arrest at the G2/M boundary of the cell cycle. To accomplish this we used the REF52 cell line and the temperature sensitive p53val135 mutant allele. Cells were enriched in the late G1 and early S phases before the temperature shift. REF52 cells expressing mutant-p53val135 alone with an activated H-ras gene arrest primarily at the G1/S and G2/M parts of the cell cycle at the restrictive temperature, as determined by flow cytometry analysis. These results suggest that the anti-proliferative activity of p53 may be involved in regulation of the cell cycle at the G2/M restriction point as well as transit through G1/S and initiation of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529916

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.

Authors:  P M Flatt; L J Tang; C D Scatena; S T Szak; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation.

Authors:  W Jongmans; M Vuillaume; K Chrzanowska; D Smeets; K Sperling; J Hall
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 4.  Control of the G2/M transition.

Authors:  George R Stark; William R Taylor
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

5.  Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.

Authors:  Sunil K Manna; Julie S Bose; Vijay Gangan; Nune Raviprakash; Thota Navaneetha; Pongali B Raghavendra; Banaganapalli Babajan; Chitta S Kumar; Swatantra K Jain
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

6.  p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.

Authors:  S Matsuzawa; S Takayama; B A Froesch; J M Zapata; J C Reed
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

7.  Long term growth arrest of human Tenon's fibroblasts following single applications of beta radiation.

Authors:  P H Constable; J G Crowston; N L Occleston; M F Cordeiro; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

8.  A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression.

Authors:  R Utrera; L Collavin; D Lazarević; D Delia; C Schneider
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Growth inhibition, G(1)-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives.

Authors:  Juan Antonio Marchal; Houria Boulaiz; Inés Suárez; Estrella Saniger; Joaquín Campos; Esmeralda Carrillo; José Prados; Miguel Angel Gallo; Antonio Espinosa; Antonia Aránega
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.